The safety of Covid-19 mRNA vaccines: a review
P Anand, VP Stahel - Patient safety in surgery, 2021 - Springer
The novel coronavirus disease 2019 (COVID-19) has infected more than 100 million people
globally within the first year of the pandemic. With a death toll surpassing 500,000 in the …
globally within the first year of the pandemic. With a death toll surpassing 500,000 in the …
Current status and future perspectives on MRNA drug manufacturing
The coronavirus disease of 2019 (COVID-19) pandemic launched an unprecedented global
effort to rapidly develop vaccines to stem the spread of the novel severe acute respiratory …
effort to rapidly develop vaccines to stem the spread of the novel severe acute respiratory …
SARS-CoV-2 vaccine development: an overview and perspectives
Y Liu, K Wang, TF Massoud… - ACS Pharmacology & …, 2020 - ACS Publications
Coronavirus disease 2019, abbreviated as COVID-19, is caused by a new strain of
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It …
coronavirus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). It …
Intracranial delivery of synthetic mRNA to suppress glioblastoma
H Peng, X Guo, J He, C Duan, M Yang, X Zhang… - Molecular Therapy …, 2022 - cell.com
Owing to messenger RNA's unique biological advantages, it has received increasing
attention to be used as a therapeutic, known as mRNA-based gene therapy. It is critical to …
attention to be used as a therapeutic, known as mRNA-based gene therapy. It is critical to …
Adverse Events Related to SARS-Cov-2 Vaccination: A Systematic Review and Meta-Analysis
Background: Vaccination has been adopted as a key public health strategy for combating
the COVID-19 pandemic. The accelerated SARS-CoV-2 vaccines' development had limited …
the COVID-19 pandemic. The accelerated SARS-CoV-2 vaccines' development had limited …
Preliminary Step towards COVID-19 Inactivated Vaccine Development in Egypt.
M Saad, AA Saleh, I Ryan, M Amin… - Archives of Clinical …, 2021 - cnrs.hal.science
The current worldwide COVID-19 pandemic is causing severe human health problems, with
high mortality rates and huge economic burdens requiring the urgent development of a safe …
high mortality rates and huge economic burdens requiring the urgent development of a safe …
Predicting the Degradation of COVID-19 mRNA Vaccine with Graph Convolutional Networks
Y Wang - Proceedings of the 2021 6th International Conference …, 2021 - dl.acm.org
The COVID-19 pandemic has generated a great demand for effective vaccines to control
SARS-CoV-2 that causes the disease. In particular, mRNA vaccines against that virus have …
SARS-CoV-2 that causes the disease. In particular, mRNA vaccines against that virus have …
[PDF][PDF] OPTIMIZATION OF MEDICAL EVALUATION STRATEGIES IN VACCINATED WOMEN ANTI COVID-19, IN ROMANIA, TO IMPROVE THE LEVEL OF …
Aim of the study. In December 2020, the first two mRNA vaccines, developed by
Pfizer/BioNTech and Moderna, were approved by the FDA in the USA. Clarification about …
Pfizer/BioNTech and Moderna, were approved by the FDA in the USA. Clarification about …
[PDF][PDF] Prospects for a new generation of influenza vaccines based on the use of mRNA
J Herrera - research.rug.nl
While generally the development of a new vaccine is a very lengthy process, the COVID-19
pandemic has profoundly changed this picture with the emergency use listing (EUL) by the …
pandemic has profoundly changed this picture with the emergency use listing (EUL) by the …
[PDF][PDF] A SYSTEMIC REVIEW ON THE SAFETY OF COVID 19 VACCINES AVAILABLE TODAY
GR Prashob - 2021 - wjpr.s3.ap-south-1.amazonaws.com
ABSTRACT A world wide competition for the development of Covid 19 vaccines was raised
due to the wide spread of SARS-CoV-2 and the resulting pandemic situation. The first two …
due to the wide spread of SARS-CoV-2 and the resulting pandemic situation. The first two …